Furthermore, fusion transcripts involving oncogenes have been shown to exhibit increased expression in cancer [58], and we observed indeed strong expression of CRYBG1, FGFR2, and RTN4IP1 in MFM-223. This evidence concerns the gene FGFR2 and cancer.